Fc gamma receptor IIIa (FCGR3A)-type and CD14-type macrophages, as well as pertinent prognostic variables, were identified using single-cell data to help predict the prognosis and response to immunotherapy in patients with STAD. The gene discussed is FCGR3A; the disease is gastric adenocarcinoma.